Seeing Is Believing
Currently out of the existing stock ratings of Donald Ellis, 32 are a BUY (94.12%), 2 are a HOLD (5.88%).
Analyst Donald Ellis works with a stock forecast success ratio of 50.63% fulfilled within 359.88 days on average.
Donald Ellis’s has documented 67 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLSD, Clearside Biomedical at 21-Dec-2021.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for CLSD (CLEARSIDE BIOMEDICAL) at 10/24/2019. The price target of $4 was fulfilled within 448 days with a profit of $3.08 (334.78%) receiving and performance score of 7.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 months ago
0/5 (0%)
$34.34 (396.54%)
Hold
3 months 11 days ago
0/2 (0%)
$21.59 (291.36%)
Hold
1.5
3 months 12 days ago
0/4 (0%)
$0.49 (48.51%)
Hold
1
$-0.19 (-15.97%)
2
4 months 4 days ago
1/4 (25%)
$0.06 (6.38%)
1
Hold
38
5 months 8 days ago
0/7 (0%)
$23.92 (169.89%)
What Year was the first public recommendation made by Donald Ellis?